Osaic Holdings’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NRIX
BBA
Osaic Holdings's NRIX Position: Q3 2026 in Review
Osaic Holdings increased its Nurix Therapeutics (NRIX) stake by 2.3% in Q3 2026, buying an estimated $6.11K and bringing the position to 10,745 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #4258.
Osaic Holdings first reported a position in NRIX in Q3 2022 and has held it in 11 quarters since. 234 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.
- Osaic Holdings held 10,745 shares of Nurix Therapeutics worth $255K as of Q3 2026.
- Osaic Holdings bought 245 Nurix Therapeutics shares in Q3 2026, an estimated $6.11K.
- Nurix Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #4258 holding.
- Osaic Holdings first reported a position in Nurix Therapeutics in Q3 2022 and has held it in 11 quarters since.
- 234 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.